Human Microbiome Market Size, Share, Trends, Demand, Growth Forecast, Segmentation and Revenue Outlook

Data Bridge Market Research analyses that the human microbiome market is expected to undergo a CAGR of 22.95% during the forecast period. This indicates that the market value, which was USD 599 million in 2021, would rocket up to USD 3,127.916 million by 2029. "Therapeutics" dominates the application segment of the human microbiome market owing to the increasing number of technological advancements and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample PDF of the Human Microbiome Market report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-human-microbiome-market

Recent Development

In September 2021, PhenoBiome today launched a human gut microbiome assay through Genetic Direction, which will process the assays in its CLIA- and CAP-certified laboratory.
In June 2021, NovoBiome, a drug discovery company has notified that they are building NovoSift, a disruptive ex-vivo research and discovery platform which will analyze the symbiotic relationship between the microbiota and the human intestine.
To improve the understanding of microbial flora pertaining to human health and various diseases, United States National Institute of Health (NIH) initiated a project named Human Microbiome Project in 2007. The first phase of this project was concerned with the identification of human microbiota and its characterisation.

Human microbiomes refers to the aggregation of microorganisms that are present on and within the human body. Human microbiome is a full array of microorganisms such as bacteria, bacteriophage, fungi, protozoa and viruses. Factually humans have 10 times more of the microbial cells than human cells.

To Gain More Insights into the Human Microbiome Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-human-microbiome-market

Global Human Microbiome Market Scope

The human microbiome market is segmented on the basis of product, application and disease type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Probiotics
Prebiotics
Medical Foods
Supplements
Others
On the basis of product, the human microbiome market in is segmented into probiotics, prebiotics, medical foods, supplements and others.

To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-human-microbiome-market

Some of the major players operating in the human microbiome market are ENTEROME (France), Yakult (US), DuPont (US), Metabiomics Corporation (US), ViThera Pharmaceuticals, Inc. (US), Second Genome Inc. (US), MICROBIOME THERAPEUTICS LLC (US), Vedanta Biosciences, Inc. (US), Osel, Inc. (US), Merck Sharp & Dohme Corp (Germany), Seres Therapeutics (US), Synthetic Biologics, Inc. (US), Synlogic (US), 4D pharma plc (UK), Metabogen AB (Sweden), Ritter Pharmaceuticals (US), Symberix (US) and Symbiotix Biotherapies, Inc. (US) among others.

Some of the launches and acquisitions in the Human Microbiome Market are:

In January 2019, OraSure Technologies announced the acquisition of CoreBiome of Minnesota and Novosanis of Belgium. This acquisition will help the company enhance their molecular collection products business. With the acquisition of CoreBiome, the company will be able to enhance their research needs for microbiome, catch new segments and extend their leading position in this competitive market and with Novisanis they will be adding new products to their Oragene DNA and RNA collection devices portfolio. Both these acquisitions will help the company to strengthen their market position and enhance their product portfolio
In April 2018, Ferring Pharmaceuticals announced the acquisition of Rebiotix Inc. This acquisition enhances their technology platform and enhances their ongoing research on microbiomes and collaborations with leading international organizations in this area. This will also help the company to increase their R&D abilities

More Links:

https://dbmrbuisness.blogspot.com/2023/01/cluster-headache-drug-market-size-share.html

https://databridgemarketresearch.medium.com/cluster-headache-drug-market-application-trends-demand-growth-challenges-and-competitive-outlook-d556eec93b8

https://www.pearltrees.com/dbmrfeed/item495139931

https://www.onfeetnation.com/profiles/blogs/cluster-headache-drug-market-size-share-trends-development?xg_source=activity

https://www.tumblr.com/dbmrmedical/706692252755443712/cluster-headache-drug-market-size-share-trends

https://writeablog.net/kn20sz2lmq

https://www.spoke.com/topics/cluster-headache-drug-market-size-share-growth-by-emerging-trends-business-strategies-developing-technologies-and-competitive-landscape-63c6840df85248bcd00009ae

https://pastelink.net/ejyzg8uj

https://filltix-design.tribe.so/post/cluster-headache-drug-market-share-demand-industry-trends-growth-opportunit-
-63c68417f8b2c363d9d674b3

https://fitbloom.tribe.so/post/cluster-headache-drug-market-share-trends-key-drivers-demand-opportunities---63c6841bf8b2c38d46d674b7

https://justpaste.it/b1h77

https://dbmrblogs.wordpress.com/2023/01/17/cluster-headache-drug-market-is-likely-to-upsurge-cagr-of-9-36-by-2029-size-share-demand-future-growth-and-challenges/

https://www.diigo.com/item/note/6nsjl/9271?k=77e8d39631f9d021d5fc2863387175a2

https://dbmrbuisness.blogspot.com/2023/01/cluster-headache-drug-market-size-share_17.html

https://databridgemarketresearch.medium.com/cluster-headache-drug-market-application-trends-demand-growth-challenges-and-competitive-outlook-f843bdeee456

https://www.pearltrees.com/dbmrfeed/item495156759

https://www.onfeetnation.com/profiles/blogs/cluster-headache-drug-market-size-share-trends-development-1?xg_source=activity

https://www.tumblr.com/dbmrmedical/706692848267984896/cluster-headache-drug-market-size-share-trends

https://writeablog.net/q4wtp8kvp0

https://www.spoke.com/topics/cluster-headache-drug-market-industry-share-size-growth-demands-revenue-top-leaders-and-application-63c686080033151fd20243e5

https://pastelink.net/gl6hrzd1

https://filltix-design.tribe.so/post/cluster-headache-drug-market-share-growth-size-opportunities-trends-regiona--63c686107124b6f006c502c3

https://fitbloom.tribe.so/post/cluster-headache-drug-market-is-likely-to-upsurge-cagr-of-9-36-by-2029-size--63c686131ca6663a1a07b512

https://justpaste.it/bao3t

https://dbmrblogs.wordpress.com/2023/01/17/laser-probe-market-by-product-type-size-share-segment-trends-and-is-grow-a-cagr-of-around-9-11-by-2028-2/

https://www.diigo.com/item/note/6nsjl/doka?k=8fdd7b84f8b96ae27241367e617fc6f9

https://dbmrbuisness.blogspot.com/2023/01/laser-probe-market-size-share-demand.html

https://databridgemarketresearch.medium.com/laser-probe-market-application-trends-demand-growth-challenges-and-competitive-outlook-7eb04ea8562d

https://www.pearltrees.com/dbmrfeed/item495167585

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.